Is it safe to start steroids at home for a COPD exacerbation after virtual assessment in the COVID-19 era?

Singh, Achintya D; Mian, Agrima; Stoller, James K

Singh, Achintya D; Mian, Agrima; Stoller, James K.

Singh AD; Resident, Department of Internal Medicine, Cleveland Clinic, Cleveland, OH singha8@ccf.org.
Mian A; Resident, Department of Internal Medicine, Cleveland Clinic, Cleveland, OH.
Stoller JK; Chairman, Education Institute; Staff, Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.

Cleve Clin J Med ; 88(4): 213-215, 2021 04 01.

Article in English | MEDLINE | ID: covidwho-1167811

Subject(s)

COVID-19; Prednisone/administration & dosage; Pulmonary Disease, Chronic Obstructive; Remote Consultation/methods; Symptom Assessment/methods; Symptom Flare Up; COVID-19/diagnosis; COVID-19/physiopathology; COVID-19/therapy; Duration of Therapy; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive/diagnosis; Pulmonary Disease, Chronic Obstructive/drug therapy; Pulmonary Disease, Chronic Obstructive/physiopathology; SARS-CoV-2; Steroids/administration & dosage; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Prednisone / Remote Consultation / Pulmonary Disease, Chronic Obstructive / Symptom Assessment / Symptom Flare Up / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans / Male / Middle aged Language: English Journal: Cleve Clin J Med Journal subject: Medicine Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google